Ionis Pharmaceuticals, Inc. Stockholders' Equity Attributable to Noncontrolling Interest
Ionis Pharmaceuticals, Inc. (IONS) had Stockholders' Equity Attributable to Noncontrolling Interest of $0 as of 2020-12-31, per its 10-K filed 2021-02-24.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2021-02-24
- 2020-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $0.00.
- 2020-09-30: Stockholders' Equity Attributable to Noncontrolling Interest $223.24M.
- 2020-06-30: Stockholders' Equity Attributable to Noncontrolling Interest $217.62M.
- 2020-03-31: Stockholders' Equity Attributable to Noncontrolling Interest $210.17M.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest | Stockholders' Equity Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-24 | |
| 2020-09-30 | $223.24M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $217.62M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $210.17M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $213.45M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $161.67M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $187.82M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $179.77M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $139.08M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $129.59M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $121.18M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $85.71M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $84.27M 10-K · filed 2019-03-01 | $87.85M 10-K · filed 2018-02-28 |
| 2017-09-30 | $89.70M 10-Q · filed 2017-11-07 | |
| 2016-12-31 | $0.00 10-K · filed 2018-02-28 | |
| 2009-12-31 | $10.34M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |